These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3280504

  • 1. Studies on the formation of a unique cellular intermediate (EAC14256) from EAC142 and C56.
    Kitamura H, Tsuboi M.
    Int Arch Allergy Appl Immunol; 1988; 85(3):322-8. PubMed ID: 3280504
    [Abstract] [Full Text] [Related]

  • 2. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
    Kitamura H, Tsuboi M, Nagaki K.
    Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
    [Abstract] [Full Text] [Related]

  • 3. Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.
    Kossorotow A, Opitz W, Etschenberg E, Hadding U.
    Biochem J; 1977 Nov 01; 167(2):377-82. PubMed ID: 597250
    [Abstract] [Full Text] [Related]

  • 4. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H, Tsuboi M, Nagaki K.
    Int Arch Allergy Appl Immunol; 1985 Nov 01; 78(1):101-7. PubMed ID: 4030125
    [Abstract] [Full Text] [Related]

  • 5. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
    Kitamura H, Matsumoto M, Nagaki K.
    Immunology; 1984 Nov 01; 53(3):575-82. PubMed ID: 6237987
    [Abstract] [Full Text] [Related]

  • 6. Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.
    Nemerow GR, Gewurz H, Osofsky SG, Lint TF.
    J Clin Invest; 1978 Jun 01; 61(6):1602-10. PubMed ID: 350902
    [Abstract] [Full Text] [Related]

  • 7. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V, Beuscher HU.
    Immunobiology; 1984 Mar 01; 166(2):177-89. PubMed ID: 6724636
    [Abstract] [Full Text] [Related]

  • 8. Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.
    Tamura N, Baba AS.
    Immunology; 1976 Jul 01; 31(1):151-8. PubMed ID: 1027719
    [Abstract] [Full Text] [Related]

  • 9. The biochemistry of complement.
    Porter RR, Reid KB.
    Nature; 1978 Oct 26; 275(5682):699-704. PubMed ID: 703835
    [Abstract] [Full Text] [Related]

  • 10. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H, Tsuboi M, Nagaki K.
    Immunology; 1986 Jul 26; 58(3):459-65. PubMed ID: 3733147
    [Abstract] [Full Text] [Related]

  • 11. The proteolytic activation systems of complement.
    Reid KB, Porter RR.
    Annu Rev Biochem; 1981 Jul 26; 50():433-64. PubMed ID: 7023363
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.
    Dessauer A, Rother U, Rother K.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Jul 26; 284():83-8. PubMed ID: 6444196
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 26; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 17. Expression and characterization of the C345C/NTR domains of complement components C3 and C5.
    Thai CT, Ogata RT.
    J Immunol; 2003 Dec 15; 171(12):6565-73. PubMed ID: 14662858
    [Abstract] [Full Text] [Related]

  • 18. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 15; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I, Sorvillo J, Mecarelli-Halbwachs L, Leibowitch J.
    J Exp Med; 1981 Jul 01; 154(1):1-12. PubMed ID: 7019379
    [Abstract] [Full Text] [Related]

  • 20. Interactions of complement with the red-cell membrane.
    Rosse WF.
    Semin Hematol; 1979 Apr 01; 16(2):128-39. PubMed ID: 384519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.